Shafiroff et al., 1952 - Google Patents

Intravenous infusions into human subjects of fractionated coconut oil emulsions

Shafiroff et al., 1952

Document ID: 562447580582745958
Author: Shafiroff B; Mulholland J; Baron H
Publication year: 1952
Publication venue: Proceedings of the Society for Experimental Biology and Medicine

External Links

Cited by

Snippet

Emulsions of the glycerides of the short chain fatty acids were toxic when injected intravenously into human subjects. 2. The glycerides of the high molecular weight fatty acids, lauric, myristic, palmitic and stearic acids were non-toxic when injected jin emulsion form. 3 …

Continue reading at journals.sagepub.com (other versions)

239000000839 emulsion 0 title abstract description 22

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Micro-organisms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/937—Dispersion or emulsion
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Similar Documents

Publication	Publication Date	Title
Mergenhagen et al.	1961	Preparation and biological activities of endotoxins from oral bacteria
Klatskin et al.	1952	Relationship between relapsing pancreatitis and essential hyperlipemia
Bloch	1950	Studies on the virulence of tubercle bacilli: isolation and biological properties of a constituent of virulent organisms
Hallberg et al.	1966	Experimental and Clinical Studies with Fat Emulsion for Intravenous Nutrition/Experimentelle und klinische Untersuchungen mit Fettemulsionen für intravenöse Ernährung/Etudes expérimentales et cliniques avec des émulsions graisseuses pour alimentation intraveineuse
JPH0786088B2 (en)	1995-09-20	Pharmaceutical composition comprising an acetone soluble lipid fraction
Bridge et al.	1945	Glycogen storage disease: observations on the pathologic physiology of two cases of the hepatic form of the disease
Lumholtz et al.	1975	Sulfamethizole‐induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism
Besterman	1957	Lipoproteins in coronary artery disease
Popjak	1946	The effect of feeding cholesterol without fat on the plasma-lipids of the rabbit. The role of cholesterol in fat metabolism
Hertelendy et al.	1966	Lipolytic activity and inhibition of insulin release by epinephrine in the pig
LeVEEN et al.	1961	The mechanism of removal of intravenously injected fat: Its relationship to toxicity
Shafiroff et al.	1952	Intravenous infusions into human subjects of fractionated coconut oil emulsions
RU2206337C1 (en)	2003-06-20	Medicinal preparation for treatment of muscle dystonia and method for its preparing
Lundholm et al.	1978	Influence of nicotinic acid, niceritrol and β-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs
CN1181826C (en)	2004-12-29	Lipid-based immune modulator composition
Fábry et al.	1970	Effect of diet and insulin on the morphology and TPNH generating enzyme activities of rat adipose tissue
Lerner et al.	1949	A fat emulsion for intravenous feeding.
CN114271497A (en)	2022-04-05	Composition capable of reducing high uric acid level in serum and application thereof
Chargaff et al.	1936	Chemical composition of Bacterium tumefaciens.
Jones et al.	1965	Toxicity testing of fat emulsions for intravenous administration
Shafiroff et al.	1956	Effects of Intravenous Infusion of Experimental “Instant” Fat Emulsion Into Volunteer Subjects.
Best	1935	The internal secretion of the pancreas
Gelb	1966	Effect of hypophysectomy, thyroidectomy, adrenalectomy and alloxan diabetes on incorporation of fatty acids into esters by the small intestine in vitro
Whelan et al.	1971	Depression of biliary excretion of infused bilirubin in rats and guinea pigs by bile
Robinson	1940	Presidential address. A. Some aspects of the chemotherapy of tuberculosis